Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...
Hosted on MSN
Kenya stepping up GM cassava seed multiplication
Even as court cases continue to stall the adoption of genetically modified (GM) crops in Kenya, stakeholders in agricultural biotechnology sector remain active. They are maintaining research and ...
Welcome to Taste Test, where every week our critic Jonah Flicker explores the most buzzworthy and interesting whiskeys in the world. Check back each Sunday for his latest whiskey review. Just because ...
Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...
Real-world physician- and patient-reported data from 2,675 cases show high multimorbidity (mean 3.6 comorbidities), dominated by hypertension, dyslipidemia, and obesity in MASH populations. EuroQol EQ ...
Editors and writers independently select products unless marked Sponsored or Promoted. Sponsored content is a paid ad, while content marked Promoted is chosen by Ziff Davis leadership. We may earn an ...
We may earn commission from links on this page, but we only recommend products we love. Promise. Listen, I’ll be the first person to tell you that homemade face masks can be a little questionable.
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
It's Stanley's first day of school but he's hiding on the Mash-Up set! 🫣 Can you spot backpack Stanley and get him to class?! 📚🏛️🕵🏽 ...
☕️ Check out awful coffee, where Strictly's Michelle and Nancy discover everything is iced!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results